Novartis | NOVN

Novartis traded at 76.39 this Wednesday March 22nd, decreasing 0.50 or 0.65 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 5.12 percent. Over the last 12 months, its price fell by 4.41 percent. Looking ahead, we forecast Novartis to be priced at 74.36 by the end of this quarter and at 69.01 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
76.39
Daily Change
-0.65%
Yearly
-4.41%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 153.67 -3.10 -1.98% -3.00%
Alcon AG 62.46 0.34 0.55% -12.13%
Almirall SA 8.66 -0.16 -1.82% -29.40%
Amgen 229.83 -3.12 -1.34% -1.86%
Artemis Alpha 317.00 2.00 0.63% -9.94%
AstraZeneca 10,978.00 74.00 0.68% 12.83%
Bayer 56.72 -0.46 -0.80% -4.56%
Biogen 261.22 -4.93 -1.85% 24.62%
Bristol-Myers Squibb 67.24 -0.27 -0.40% -5.80%
Fresenius Medical Care 37.66 0.54 1.45% -36.43%
Fresenius 24.30 -0.07 -0.29% -24.26%
Genmab 2,528.00 -19.00 -0.75% 6.67%
Gilead Sciences 77.81 -1.33 -1.68% 32.22%
Galapagos 35.03 -0.50 -1.41% -39.44%
GRIFOLS 8.69 -0.20 -2.21% -45.11%
GlaxoSmithKline 1,438.40 10.40 0.73% -10.80%
Hikma Pharmaceutical 1,705.00 5.50 0.32% -17.99%
J&J 151.05 -2.84 -1.85% -13.36%
Eli Lilly 330.97 -0.11 -0.03% 16.46%
Lonza Group 539.20 3.00 0.56% -18.43%
Merck 164.70 -2.80 -1.67% -9.63%
Merck & Co 104.40 -1.14 -1.08% 30.94%
Novartis 76.39 -0.50 -0.65% -4.41%
Orion 43.08 -0.41 -0.94% 0.87%
Pfizer 40.01 -0.65 -1.60% -23.34%
Philips 15.41 0.10 0.63% -43.58%
Recordati 38.92 -0.15 -0.38% -15.15%
Regeneron Pharmaceuticals 751.30 -8.46 -1.11% 12.27%
Roche Holding 261.15 -1.55 -0.59% -28.56%
Sanofi 90.73 0.55 0.61% -3.09%
UCB 78.32 -0.68 -0.86% -26.18%

Indexes Price Day Year
CH20 10782 -10.30 -0.10% -10.89%

Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.